181 related articles for article (PubMed ID: 32410217)
1. Development of an RNA sequencing-based prognostic gene signature in multiple myeloma.
Zamani-Ahmadmahmudi M; Nassiri SM; Soltaninezhad F
Br J Haematol; 2021 Jan; 192(2):310-321. PubMed ID: 32410217
[TBL] [Abstract][Full Text] [Related]
2. Identification of pathway-based prognostic gene signatures in patients with multiple myeloma.
Zamani-Ahmadmahmudi M; Dabiri S; Nadimi N
Transl Res; 2017 Jul; 185():47-57. PubMed ID: 28549851
[TBL] [Abstract][Full Text] [Related]
3. Development of a Reproducible Prognostic Gene Signature to Predict the Clinical Outcome in Patients with Diffuse Large B-Cell Lymphoma.
Zamani-Ahmadmahmudi M; Nassiri SM
Sci Rep; 2019 Aug; 9(1):12198. PubMed ID: 31434961
[TBL] [Abstract][Full Text] [Related]
4. Identification and validation of potential prognostic lncRNA biomarkers for predicting survival in patients with multiple myeloma.
Zhou M; Zhao H; Wang Z; Cheng L; Yang L; Shi H; Yang H; Sun J
J Exp Clin Cancer Res; 2015 Sep; 34(1):102. PubMed ID: 26362431
[TBL] [Abstract][Full Text] [Related]
5. One-lincRNA and five-mRNA based signature for prognosis of multiple myeloma patients undergoing proteasome inhibitors therapy.
Liu Y; Yang N; Peng X; Liu G; Zhong H; Liu L
Biomed Pharmacother; 2019 Oct; 118():109254. PubMed ID: 31357080
[TBL] [Abstract][Full Text] [Related]
6. MMRFBiolinks: an R-package for integrating and analyzing MMRF-CoMMpass data.
Settino M; Cannataro M
Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33821961
[TBL] [Abstract][Full Text] [Related]
7. An interactive nomogram based on clinical and molecular signatures to predict prognosis in multiple myeloma patients.
Liu L; Qu J; Dai Y; Qi T; Teng X; Li G; Qu Q
Aging (Albany NY); 2021 Jul; 13(14):18442-18463. PubMed ID: 34260414
[TBL] [Abstract][Full Text] [Related]
8. A nomogram for predicting prognosis of multiple myeloma patients based on a ubiquitin-proteasome gene signature.
Ji D; Liu Y; Sun W; Shi Q; Chen G; Song Z; Jiang Y
Aging (Albany NY); 2022 Dec; 14(24):9951-9968. PubMed ID: 36534449
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of esterase gene expression in multiple myeloma.
Kumari R; Majumder MM; Lievonen J; Silvennoinen R; Anttila P; Nupponen NN; Lehmann F; Heckman CA
Br J Cancer; 2021 Apr; 124(8):1428-1436. PubMed ID: 33531688
[TBL] [Abstract][Full Text] [Related]
10. Potential prognostic long non-coding RNA identification and their validation in predicting survival of patients with multiple myeloma.
Hu AX; Huang ZY; Zhang L; Shen J
Tumour Biol; 2017 Apr; 39(4):1010428317694563. PubMed ID: 28378636
[TBL] [Abstract][Full Text] [Related]
11. Using MMRFBiolinks R-Package for Discovering Prognostic Markers in Multiple Myeloma.
Settino M; Cannataro M
Methods Mol Biol; 2022; 2401():289-314. PubMed ID: 34902136
[TBL] [Abstract][Full Text] [Related]
12. Identification of novel fusion transcripts in multiple myeloma.
Lin M; Lee PL; Chiu L; Chua C; Ban KHK; Lin AHF; Chan ZL; Chung TH; Yan B; Chng WJ
J Clin Pathol; 2018 Aug; 71(8):708-712. PubMed ID: 29453220
[TBL] [Abstract][Full Text] [Related]
13. RNA-Sequencing from Low-Input Material in Multiple Myeloma for Application in Clinical Routine.
Seckinger A; Bähr-Ivacevic T; Benes V; Hose D
Methods Mol Biol; 2018; 1792():97-115. PubMed ID: 29797254
[TBL] [Abstract][Full Text] [Related]
14. Development of a RNA-Seq Based Prognostic Signature in Lung Adenocarcinoma.
Shukla S; Evans JR; Malik R; Feng FY; Dhanasekaran SM; Cao X; Chen G; Beer DG; Jiang H; Chinnaiyan AM
J Natl Cancer Inst; 2017 Jan; 109(1):. PubMed ID: 27707839
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia-Immune-Related Gene SLC19A1 Serves as a Potential Biomarker for Prognosis in Multiple Myeloma.
Li W; Yuan P; Liu W; Xiao L; Xu C; Mo Q; Xu S; He Y; Jiang D; Wang X
Front Immunol; 2022; 13():843369. PubMed ID: 35958555
[TBL] [Abstract][Full Text] [Related]
16. Translating a gene expression signature for multiple myeloma prognosis into a robust high-throughput assay for clinical use.
van Laar R; Flinchum R; Brown N; Ramsey J; Riccitelli S; Heuck C; Barlogie B; Shaughnessy JD
BMC Med Genomics; 2014 May; 7():25. PubMed ID: 24885236
[TBL] [Abstract][Full Text] [Related]
17. A RNA sequencing-based six-gene signature for survival prediction in patients with glioblastoma.
Zuo S; Zhang X; Wang L
Sci Rep; 2019 Feb; 9(1):2615. PubMed ID: 30796273
[TBL] [Abstract][Full Text] [Related]
18. Gene signature combinations improve prognostic stratification of multiple myeloma patients.
Chng WJ; Chung TH; Kumar S; Usmani S; Munshi N; Avet-Loiseau H; Goldschmidt H; Durie B; Sonneveld P
Leukemia; 2016 May; 30(5):1071-8. PubMed ID: 26669975
[TBL] [Abstract][Full Text] [Related]
19. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
Sun R; Limkin EJ; Vakalopoulou M; Dercle L; Champiat S; Han SR; Verlingue L; Brandao D; Lancia A; Ammari S; Hollebecque A; Scoazec JY; Marabelle A; Massard C; Soria JC; Robert C; Paragios N; Deutsch E; Ferté C
Lancet Oncol; 2018 Sep; 19(9):1180-1191. PubMed ID: 30120041
[TBL] [Abstract][Full Text] [Related]
20. A Novel Prognostic Signature of mRNA-lncRNA in Breast Cancer.
Liu Q; Wang Z; Kong X; Wang X; Qi Y; Gao R; Fang Y; Wang J
DNA Cell Biol; 2020 Apr; 39(4):671-682. PubMed ID: 32040341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
